Web Summary
Q1: What is the address of Sami Lab Ltd.?
A1: The address of Sami Lab Ltd. is 19/1 & 19/2, I Main, II Phase Peenya Industrial Area, Bangalore 560058, India.
Q2: What products does Sami Lab Ltd. offer?
A2: Sami Lab Ltd. offers a wide range of products including Phytochemicals for Nutritional Use, Standardized Phyto Extracts, Super Critical Fluid (SCF) Extracts, Specialty Chemicals, Nutraceutical Ingredients, Multienzyme Blends, Prebiotics, Probiotics, Postbiotics & Synbiotics, Minerals for Nutritional Use, Natural Protein, GRAS Affirmed Products, Beverage/Liquid Dietary Ingredients, Geroceuticals™ Phyto Functional Blends, Cosmeceutical Ingredients, and Natural Actives.
Q3: What is the industry of Sami Lab Ltd.?
A3: The industry of Sami Lab Ltd. is primarily in the field of Nutraceuticals and Specialty Chemicals, with a focus on developing innovative phytochemicalbased products for various applications including nutritional supplements, functional foods, and cosmetics.
Q4: What services does Sami Lab Ltd. offer?
A4: Sami Lab Ltd. offers various services including Contract Farming, Contract Research, Publications, Coffee Table Book, Popular Articles, Research Papers, Newsroom, Ads, Annual Returns, Books, Events, Media Coverage, Presentations, and Press Releases.
Q5: What is the contact information of Sami Lab Ltd.?
A5: The contact information of Sami Lab Ltd. includes Phone numbers +91 80 6852 7777, +91 80 2839 7974, 75, 78, and Email address info@samisabinsagroup.com.
Q6: What is the status of Calebin A (CurCousin™) in terms of patents?
A6: Calebin A (CurCousin™) has been patented under various international patent numbers including AU2014203764, AU2014203122, AU2014202312, AU2014201769, AU2012366253, CA2963383, CA2941050, CA2935898, CA2893321, CA2858126, CA2857543, CA2850999, EA027726, EA027614, EA027148, EP3085370, EP2963007, EP2937084, EP2893926, EP2663185, HK1217689, HK1210590, HK1210028, HK1190874, I622384, IDP000067993, IDP000064827, JP6490927, JP6374716, JP6336943, JP6263707, JP6142446, KR101763474, KR101702702, KR101685333, KR101685263, KR101647549, KR101629561, MY182000A, MY175867A, MY170067A, NZ715053, NZ627247, NZ624269, NZ622909, NZ614076, PH12016501138, PH12015000188, PH12014000244, RU2653103, RU2643297, RU2543334, SG11201605336Y, SG10201503805X, SG192695, US 9,737,502, US 9,668,999, US 9,610,273, US 9,539,232, US 9,365,486, US 9,328,330, US 9,220,703, US 8,933,121, ZA2013/05918, and ZL201280012577.3.
Q7: What is the status of Oxyresvenox ® (Resvenox ®) in terms of patents?
A7: Oxyresvenox ® (Resvenox ®) has been patented under various international patent numbers including US 7,253,324 and US 9,737,502.
Q8: What is the disclaimer statement regarding the products offered by Sami Lab Ltd.?
A8: The disclaimer statement regarding the products offered by Sami Lab Ltd. states that the information provided on the website is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers. The statements related to ingredients on the website have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.